drugset / Trial / NCT04859764

Effect of Reparel Knee Sleeve With Knee Injection

NCT04859764

Completed 40 enrolled University of Alabama at Birmingham
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goals of treating knee osteoarthritis (OA) is to improve or maintain quality of life, mobility and function, pain relief, and improve inflammation. The different treatment options for knee OA have been extensively studied and implemented, but the optimum treatment is still undecided. There is a belief that anti-inflammatory sleeve technology may be beneficial in treating knee OA. The purpose of this study is to determine if the Reparel™ knee sleeve results in superior mobility, functionality, and pain outcomes as compared to a placebo knee sleeve in managing knee OA.

Timeline

Start
2022-06-29
Primary completion
2025-12-01
Completion
2025-12-03

Drugs

EvaluationDrugModalityDoseRoute
Background Betamethasone Other / unclassified Other
Background Bupivacaine Other / unclassified 0.5 % Other

Indications